Author: Sepesi, Boris; Cascone, Tina; Chun, Stephen G.; Altan, Mehmet; Le, Xiuning
Title: Emerging Therapies in Thoracic Malignancies—Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non–Small Cell Lung Cancer Cord-id: nqvag4a9 Document date: 2020_7_29
ID: nqvag4a9
Snippet: Immunotherapy, targeted therapy, and adoptive T-cell therapy have been revolutionary advancements in cancer research. Some of these therapies have become the standard of care for lung cancer and replaced older treatment algorithms; some continue to be studied in clinical trials. This article discusses the current state of novel treatment options for non–small cell lung cancer patients with metastatic and locoregional disease, with focus on immunotherapy, targeted therapy, and adoptive T-cell t
Document: Immunotherapy, targeted therapy, and adoptive T-cell therapy have been revolutionary advancements in cancer research. Some of these therapies have become the standard of care for lung cancer and replaced older treatment algorithms; some continue to be studied in clinical trials. This article discusses the current state of novel treatment options for non–small cell lung cancer patients with metastatic and locoregional disease, with focus on immunotherapy, targeted therapy, and adoptive T-cell therapy.
Search related documents:
Co phrase search for related documents- academic center and adjuvant therapy: 1
- academic center and locally advanced: 1
- academic center and long term outcome: 1
- academic center and lung cancer: 1, 2
- academic center and lymph node: 1
Co phrase search for related documents, hyperlinks ordered by date